We have designed a ribozyme (Rz) that cleaves human interleukin-6 (IL-6) mRNA in vivo. This Rr was tested in vitro, and was found to give expected size fragments. It was then incorporated into a mammalian expression vector containing the constitutive cytomegalovirus (CMV) immediate early promoter and transfected into human U amniotic cells (UAC). Cell clones that stably express this catalytic RNA have been obtained. Some of them displayed a marked reduction of tumor necrosis factor (TNF)-induced IL-6 production. Their I NTERLEUKIN-6 (IL-6) is a pleiotropic cytokine mainly involved in the regulation of inflammatory and immunologic processes.' Among its major roles, it triggers the production of acute-phase proteins by hepatocytes, activates proliferation and differentiation of cytotoxic T cells, and stimulates the terminal differentiation of B lymphocytes; it is also a growth factor for murine hybridoma and plasmacytoma cell lines. Furthermore, it has been implicated in several pathologies as a potent growth factor (perhaps among others), for example, in multiple and in Kaposi's sarcoma." In this study, we have attempted to develop a ribozyme (Rz) capable of specifically cleaving human IL-6 mRNA in vitro and in vivo, and therefore inhibiting IL-6 production.
reduced ability to express IL-6 was related to the amount of Rz they produced and to the extent of IL-6 mRNA cleavage as observed by a ribonuclease protection assay. These data provide a method to study further the role of IL-6 production in various biologic situations, and suggest the feasibility of developing Rzs directed against various cytokines to study their biologic role and mechanism of action.
0 1994 by The American Society of Hematology. mRNA has been designed, characterized, and expressed in UAC amniotic cells.
MATERIALS AND METHODS

Oligonucfeotide Synthesis
Synthetic oligodeoxyribonucleotides were prepared on an Applied Biosystems DNA Synthesizer 381A (Maarssen, The Netherlands). The sequences for the oligodeoxyribonucleotides were as follows.
(1) Oligodeoxyribonucleotides used to clone the IL-6 Rz DNA into pBluescript (pBS) I1 SK (Stratagene, La Jolla, CA)-IL-6 Rz 56: 
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Plasmid Constructions
The Rz double-stranded DNA obtained by the annealing of the two synthetic single-stranded oligonucleotides IL-6.Rz 56 and IL-6.Rz 48 was cloned into a Kpn I-and HindIII-digested pBluescript 11 SK pBS IL-6.Rz. The sequence and orientation of the inserts were confirmed by dideoxynucleotide sequencing of the construct. For in vivo assays, the IL-6Rz was cloned into the pRclCMV mammalian expression vector (Invitrogen, Oxon, UK) downstream to the constitutive CMV immediate early promoter and was followed by the SV40 polyadenylation signal (pRclCMV-IL-6.Rz).
In Vitro Transcription of Rz and IL-6 mRNA
The transcription reactions were performed using 1 pg of Linearized DNA template in 0.4 mmolfL each of adenosine triphosphate (ATP), guanosine triphosphate (GTP), and cytidine triphosphate (CTP), +0.2 mmol/L cold undine triphosphate (UTP), 8 m o V L MgC12, 2 mmol/L spermidine, S mmoVL dithiothreitol (DDT), 40 mmoVL Tris-HCI (pH 8), 25 mmoVL NaCI, and 2 Ulpl l7 RNA polymerase. If 3ZP-labeled transcripts were needed, IS pCi of [cr"P]-UTP (3,000 Ci/mmol) was included. The reactions were performed at 37°C for 1 hour, treated for 15 minutes with RNase-free DNase to degrade the template DNA, and the products isolated by phenol chloroform extraction and ethanol precipitation. The amount of labeled transcripts was determined by cold 10% trichloroacetic acid (TCA) precipitation. IL-6 mRNA was transcribed from Sal I-linear- Design of the Rz directed against human 11-6 mRNA. The 11-6 mRNA target region contains a GUC cleavage site at 510 nucleotides from the cap site on IL-6 mRNA, corresponding t o aa 121 of the mature IL-6. The in vitro-transcribed IL-6 mRNA was used as substrate. (----) A vector-derived sequence, which is not present in natural 11-6 mRNA. P1 and P2 are cleaved fragments of this synthetic messenger RNA. The in vitro-transcribed hammerhead IL-6 Rz contains vector-derived flanking sequences, indicated in oblique. Shaded nucleotides represent the catalytic domain.
ized pEMBL l7DL-6 plasmid (containing the IL-6 cDNA)." The product of in vitro transcription corresponds to the 1,041 full-length nonpolyadenylated human IL-6 mRNA. Rz was transcribed from EcoRI-digested pBS IL-6.Rz.
Rz-Mediated mRNA Cleavage In Vitro
Reactions were performed in 50 mmol/L Tris-HCI, pH 8. and 20 mmol/L MgCI2 (sometimes in the presence of human placental ribonuclease inhibitor). Reactants (Rz and target RNA) were mixed together at the desired molar ratios and the reactions were initiated by adding MgCI2. The reactions were stopped by the addition of an equal volume of 95% formamide, 20 mmol/L EDTA, 0.05% bromophenol blue, and 0.05% xylene cyano1 FF. Reaction products were then separated on a 4% polyacrylamide/8-mol/L urea gel. The substrate and cleavage products were visualized by autoradiography and quantified by densitometric scanning at 500 nm in a DU-8 spectrophotometer (Beckman, Palo Alto, CA). The extent of cleavage products was determined as PI + P2/P1 + P2 + S .
Stable Transfection of IL-6 Rz in UAC Cells
UAC human amniotic cells were kindly provided by Dr K. Cantell (Helsinki, Finland). These cells produce IL-6 after tumor necrosis factor-a (TNF-a) induction as described by Snyers and Content."' Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum, penicillin, and streptomycin at 37°C and 5% COz. Ten micrograms of unlinearized pRc/CMV.lL-6. Rz plasmid was transfected into cells by calcium phosphate precipitation." Before transfection, the construct was purified on a Qiagen anion-exchange column (Westburg, Leusden, The Netherlands). Multiple stable neomycin-resistant clones were isolated.
IL-6 Bioassay
IL-6 activity was measured using the IL-6-dependent mouse hybridoma cell line 7TDI.'X.l" Briefly, 7TDI cells were cultivated in flat-bottom microwell plates that contained 2 X IO' cells per well in the presence of serial dilutions of supernatant. After 4 days of culture, the number of surviving cells was determined by a colorimetric assay for hexosaminidase. In this assay, the absorbancy is proportional to the number of cells present in each culture. IL-6 activity was expressed in laboratory units (LU) per milliliter; 1 LU is defined as the dilution giving half the maximal proliferation level of 7 T D 1 cells. One unit corresponds to approximately 1 pg of L-6. Interassay variability was corrected by the use of a recombinant L 6 internal standard. Each sample was tested in triplicate, and the corresponding means and standard deviations are presented.
PCR
RNA and DNA extraction. Total cellular RNA was obtained using the rapid guanidinium thiocyanate method as described by Chomczynski and Sacchi. 72°C for 2 minutes). The PCR-amplified products were analyzed by electrophoresis in a l % agarose gel in Tris-acetate EDTA buffer and blotted to a nylon membrane. Blots were hybridized to a specific "P-labeled oligonucleotide probe (IL-6.Rz 48) at 68°C in 6X SSC ( I X SSC = 0.1 5 mol/L NaCl + 0.01 5 mol/L sodium citrate). SX Denhardt's solution, 1% SDS, and 100 pglmL herring-sperm DNA. Membranes were washed three times in 2X SSC and 0.056 SDS for I 5 minutes at room temperature, and once in 2X SSC and 0. I % SDS for 30 minutes at 65°C.
RNase Protection Assay
Total cellular RNA was analyzed with a "P-labeled complementary RNA probe.
Prepararion of RNA probe.
To construct the pRS.IL-6 probe, the Acc Ihlunted Run I restriction fragment of human IL-6 cDNA was cloned in Acc I l S m I-digested pBS-KS vector (Vector Cloning Systems. La Jolla, CA). After Xho I linearization of the pBS.IL-6 plasmid. the antisense probe was prepared by in vitro transcription with T7 RNA polymerase using [o'?P]-UTP (400 Cilmmol) and precipitated after phenol-chloroform extraction.
Hyhridizafion. Hybridization reactions (30 pL), containing 50 pg RNA and the "P-labeled probe (500.000 cpm), were performed in 40 mmol/L piperazine-N,N'-bis[2-ethane-sulfonic acid] (PIPES), pH 6.4, 80% formamide. 400 mmol/L NaCI, and 1 mmol/L EDTA. Samples were heated for 10 minutes at 85°C and then incubated overnight at 48°C as previously described."
RNase freafmenf. To each sample incubated overnight, 350 pL of a solution containing 10 mmollL Tris-HCI (pH 7.5). 5 mmol/L EDTA, 300 mmol/L NaCI, 20 pL SDS 10%. 40 pglmL RNase A, and 2 pglmL RNase TI were added and incubated for 30 minutes at 37°C. After RNase digestion, 2 pL proteinase K (10 mglmL) was added, followed by further incubation for 15 minutes at 37°C. The RNA was then extracted with phenol-chloroform-isoamylalcohol (25:24:1) and precipitated with ethanol. The pellet was resuspended in 24 pL of formamide plus dye and analyzed on a 6% polyacrylamidel7-moVL urea gel. Gel was exposed overnight to an x-ray film at -70°C with an intensifying screen.
RESULTS
Rz-Mediated Cleavage of IL-6 mRNA In Vitro
A hammerhead Rz directed at the GUC sequence located at 510 nucleotides of IL-6 mRNA (Fig 1) was introduced into a pBluescript I1 SK plasmid. With this construct as template, IL-6 Rz was synthesized in vitro by T7 RNA polymerase.
In vitro cleavage of IL-6 mRNA by this IL-6 Rz was demonstrated directly using a labeled IL-6 mRNA substrate. The sizes of the fragments produced by the ribozyme cleavage were 662 (PI) and 379 (P2) nucleotides as predicted by the location of the single site of cleavage (Fig 2A, PI and  P2 ). As expected, cleavage did not occur without MgC& (Fig  2A, lane l) . In this experiment, cleavage reactions were performed for 1 hour in 20 mmol/L MgC& at 50°C. To characterize further these Rz's activities in vitro, additional assays were conducted. Various Mg" concentrations were tested. Figure 2B shows that the percentage of cleavage obtained after 30 minutes at 37°C increased with the MgC12 concentration from 2 mmol/L to 40 mmol/L; it varied from approximately 23% to 32% for MgCI2 concentrations of I O mmol/L and 40 mmol/L, respectively. These high Mg2+ optimal concentrations are consistent with hammerhead Rz's activities observed in previous reports.9.22 Moreover, it was observed that this Rz was active at 15, 20, and 60°C. At 15"C, substrate cleavage was less efficient and no cleavage was detected at 4°C. At 60"C, RNA was also unspecifically degraded (data not shown). Several experiments were performed varying the IL-6 substrate to Rz ratio (data not shown). No cleavage was observed with excess of substrate.
For an Rz to IL-6 mRNA ratio of lO:l, cleavage was slightly detectable after 1 hour at 37°C. Cleavage increased with increasing Rz to mRNA IL-6 ratios and leveled off beyond a ratio of approximately 50 to 100: 1. The plot of percentage of product versus time (Fig 3) also demonstrates that for an Rz to IL-6 mRNA ratio of 14: l , more than one third of the IL-6 mRNA was approximately cleaved within 15 minutes. Almost 80% of the IL-6 mRNA was cleaved after 2 hours of incubation at 37°C.
IL-6 Rz Activity In Vivo
DNA encoding the IL-6 Rz was cloned into a pRc/CMV plasmid under the control of the constitutive CMV immediate early promoter (pRc/CMV.IL-6 Rz). As it has vectorderived sequences at its 5' end and a polyA tail at its 3' end, this in vivo-expressed Rz is structurally different from the in vitro Rz. Amniotic UAC cells were transfected with this construct by the calcium phosphate precipitation method. A large number of neomycin-resistant clones were obtained and further analyzed, but only four of them are described here (R3, R9, R16, and R21). To demonstrate that the Rz DNA was indeed present and expressed in transfectant cell clones, total DNA and RNA from different clones were submitted to a PCR amplification assay using specific primers (Fig 4A) . IL-6 Rz DNA (Fig 4B) was detected in each clone tested (lanes 4 through 7), whereas none was detected in untransfected UAC cells (lane 3). As shown in Fig 4, clones varied in the amount of amplified DNA. For example, clone R3 and R9 (lanes 4 and 5, respectively) showed less amplification of DNA than clones R16 and R21 (lanes 6 and 7). probably representing differences in copy number. Furthermore, clones that presented less DNA amplification also had less Rz expression (Fig 4C) .
To evaluate the effect of IL-6 Rz on its target mRNA in vivo, a PCR amplification using primers specific to IL-6
For personal use only. on October 26, 2017. by guest www.bloodjournal.org From 3762 mRNA was performed (Fig 5A and B) . When untransfected UAC cells were not induced for IL-6 production, a low basal level of IL-6 mRNA (indicated by a PCR product of 596 bp) was nevertheless detected (Fig 5B, lane 3) . The clone R3 (lane 4), with the low expression of Rz as demonstrated in Fig 4C, presented a level of IL-6 mRNA expression similar to that of untransfected induced UAC cells (lane 2). However, when the Rz was highly expressed, as demonstrated for clones R16 and R21, the level of IL-6 mRNA was only slightly higher than the basal rate (lanes 5 and 6). The actin PCR amplification (lower panel) shows no significative differences in the amount of total RNA amplified.
After evaluation of IL-6 mRNA expression, the clones were tested for IL-6 production following induction with different concentrations of TNF (Fig 6A) . Only two TNF doses are presented in Fig 6B. The extent of inhibition observed between the clones was reproducible in various experiments. In summary, IL-6 production, in clones presenting higher Rz expression (R16, R21), was decreased as compared with UAC control, whereas low producing clones (R3, R9) displayed a normal level of IL-6 production. Furthermore, the higher the level of IL-6 production, the lower the relative effect of the Rz (Fig 6A) . Indeed, induction of L -6 by low doses of TNF (0.1 to 0.3 ng/mL) resulted in greater than 97% inhibition of IL-6 activity. With higher TNF doses (20 to 30 ng/mL), the inhibition reached only 85% to 90%. Seemingly, high Rz to substrate ratios are required for Rz inhibitory function in vivo, as previously suggested." Inversely, in Fig 6B, the relative increased effect of the Rz observed with higher TNF inductions is probably due to the lower production of IL-6 obtained in this experiment. For TNF induction of 3 ng/mL, the IL-6 production observed in
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UAC was approximately 2,000 U/mL in Fig 6A, compared with 386 U/mL in Fig 6B. Additionally, clones expressing high levels of IL-6 Rz and low levels of IL-6 protein at 4 months of culture (R16, R21) presented an IL-6 production similar to that of untransfected cells at 6.5 months. Additional experiments showing that expression of the Rz RNA and presence of the construct (assayed by PCR) declined between 4 and 6.5 months after isolation of the clones suggest that the inhibition in L 6 expression observed in some clones UAC is, in fact, dependent on the Rz expression (data not shown).
To demonstrate that the Rz effect observed on the IL-6 messenger RNA expression was due at least partly to its catalytic activity (and not only to an antisense effect), in vivo cleavage products were searched after RNase protection with a 274-nucleotide antisense probe covering the site of interaction and cleavage by the IL-6 Rz. As demonstrated in Fig 7A, Taken together, all the above-described in vivo experiments prove that the decrease of IL-6 production and of its mRNA expression correlate with an IL-6 Rz catalytic activity. 
DISCUSSION
In this study, we provide evidence that an Rz we have constructed to cleave human IL-6 mRNA is effectively active both in vitro and in vivo. It is important to note that the two Rzs, expressed in vitro or in vivo, are structurally different. Main differences of these basically identical Rzs are in the length and composition of the non-base-pairing flanking sequences attributed to a polyA tail. The in vitro transcript Rz counts 15 vector-derived bases at the 5' end, and 12 vector-derived bases at the 3' end. The base-pairing sequences consist in l l and 13 nucleotides at the 5' and 3' ends of the Rz, respectively. The full length of this transcript 
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is 73 nucleotides (Fig 1) . Taking various studies into account, Ellis and Rogers" consider that the rate limiting step is likely to be either "finding the target" or "refolding the substrate and Rz to form the active hammerhead complex."22 Furthermore, in this study, the products of cleavage have been directly detected in vivo by an RNase protection assay. Usually, with less sensitive methods (as Northern blot for instance), these fragments could not be detected and the effect due to the Rz was only evaluated by the degree of reduction of the corresponding target. Moreover, in most cases, the Rz inhibition could also be due to its antisense effect as demonstrated with mutations of its catalytic dohave been described in a few other Rz studies: Steinecke et a12' used RNase protection to prove hydrolytic cleavage by their Rz, but only the 5"cleavage product was detected, probably because it has a cap structure and was better protected against 5'-+3' exonuclease activity than the unprotected 5' end of the 3' cleavage product. Dropulic et a l Z 8 used PCR to quantify cleaved and uncleaved RNAs in Rzcontaining cells infected with HIV-1. In our RNase protection experiments, in vivo cleavage was clearly demonstrated and corresponded to the protection of two RNA fragments of 75 nucleotides (pP2) and 199 nucleotides (pP1) exactly as predicted. In addition, a larger protected fragment of approximately 78 to 80 nucleotides was observed on in vitro and in vivo cleavages. It probably could be due to an unspecific hybridization of the probe, because it was also observed in untransfected UAC cells and in clones with low Rz activity (R3 and R9). As suggested above, the decrease of IL-6 production and of its mRNA expression correlates with the level of the IL-6 Rz catalytic activity; however, an additional antisense effect cannot be excluded.
Southern blot analysis showed that the instability of the pRc/CMV constructs observed in our transfected clones is main,21.26.27 On the other hand, in vivo cleavage products transfected clones R3 and R9, respectively. Lanes 6 and 7, induced transfected clones R16 and R21, respectively. Lanes 8 and 9, in vitro cleavage reactions without and with Rz, respectively (excess 4 x Rz, 10 minutes, 50°C). All these assays were performed with RNAs extracted at 4 months of culture. The bands indicated on the right correspond to the protected 3' (pp11 and 5' (pP2) cleavage fragments of the 11-6 mRNA.
For personal use only. on October 26, 2017. by guest www.bloodjournal.org From RIBOZYME DIRECTED AGAINST HUMAN IL-6 mRNA 3765 probably due to its episomal form in UAC cells (data not shown). The reasons for this episomal form remain unclear. The plasmid was poorly integrated in genomic DNA, perhaps because it had not been linearized before transfection. The episomal form was shown to be unreplicated and was thus probably progressively diluted.
This study shows that the Rz-mediated inhibition of IL-6 expression was more efficient when IL-6lmRNA to Rz ratios were low. Therefore, to prevent IL-6 overexpression in some pathologic situations, ie, myeloma and Kaposi's sarcoma, other techniques might be explored. Besides the use of eukaryotic mammalian expression vectors, it should also be possible to use chemically modified Rzs with enhanced stability, which are then introduced into cells, by high-performance transfection techniques.
The in vivo activity of this IL-6 Rz should stimulate further work to elucidate the role of IL-6 in various pathologies. Similar approaches could be applied, in principle, to many other cytokines or growth factors.
